SNCA and Parkinson disease: α-synuclein has been widely explored in PD and other synucleinopathies [118,119,120], where its aggregation impairs neuronal, synaptic, and mitochondrial functions along with protein degradation pathways, ensuring its role in PD pathogenesis [121].